A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery

NCT ID: NCT06890533

Last Updated: 2025-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

560 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-30

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group 1

Group Type EXPERIMENTAL

Experimental: YZJ-4729

Intervention Type DRUG

Loading dose + demand dose

Experimental Group 2

Group Type EXPERIMENTAL

Experimental: YZJ-4729

Intervention Type DRUG

Loading dose + demand dose

Placebo Comparator

Group Type PLACEBO_COMPARATOR

Placebo Comparator: Saline

Intervention Type DRUG

Loading dose + demand dose

Active Comparator

Group Type ACTIVE_COMPARATOR

Active Comparator: Morphine

Intervention Type DRUG

Loading dose + demand dose

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental: YZJ-4729

Loading dose + demand dose

Intervention Type DRUG

Placebo Comparator: Saline

Loading dose + demand dose

Intervention Type DRUG

Active Comparator: Morphine

Loading dose + demand dose

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Be able to understand the study purpose and cooperate with the study procedures of this trial, voluntarily provide written informed consent
2. Body mass index (BMI) ≥18 kg/m2 and ≤28 kg/m2.
3. ASA I - II
4. Experiences a pain intensity rating of moderate to severe acute pain following abdominal surgery, with a pain intensity score of ≥4 on a Numeric Rating Scale (NRS) within 4 hours post-surgery

Exclusion Criteria

1. Allergy to opioids and other medications that may be used during the trial.
2. Nervous system disorders (e.g. epilepsy)
3. Psychiatric disorders (e.g. depression)
4. History of difficult airways
5. Random blood glucose ≥11.1 mmol/L
6. Uncontrolled blood pressure \[e.g., hypertension (systolic blood pressure ≥160 mmHg, diastolic blood pressure ≥100 mmHg),or hypotension(systolic blood pressure \<90 mmHg)\]
7. Abnormal pulse oxygen saturation (SpO2 \<90 %)
8. Abnormal liver function or renal function
9. Used agents that could affect the analgesic response
10. Used agents that could affect drug metabolism
11. Has previously participated in another YZJ-4729 clinical study
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cangzhou Central Hospital

Cangzhou, , China

Site Status

Cangzhou People's Hospital

Cangzhou, , China

Site Status

Changde First People's Hospital

Changde, , China

Site Status

Changsha Hospital Affiliated to Hunan University

Changsha, , China

Site Status

The Fourth Hospital OF Changsha

Changsha, , China

Site Status

The Third Xiangya Hospital of Central South University

Changsha, , China

Site Status

Sichuan Provincial People's Hospital

Chengdu, , China

Site Status

The Second People's Hospital of Chengdu

Chengdu, , China

Site Status

The Third People's Hospital of Chengdu

Chengdu, , China

Site Status

The First Affiliated Hospital of Chongqing Medical University

Chongqing, , China

Site Status

The Second Affiliated Hospital of Chongqing Medical University

Chongqing, , China

Site Status

The First Hospital of Jilin University

Ch’ang-ch’un, , China

Site Status

Affiliated Zhongshan Hospital of Dalian University

Dalian, , China

Site Status

Deyang People's Hospital

Deyang, , China

Site Status

Dongguan People's Hospital

Dongguan, , China

Site Status

Ganzhou People's Hospital

Ganzhou, , China

Site Status

The First People's Hospital of Guangyuan

Guangyuan, , China

Site Status

Guangdong Province Traditional Chinese Medical Hospital

Guangzhou, , China

Site Status

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, , China

Site Status

The First Affiliated Hospital of Jinan University

Guangzhou, , China

Site Status

Haikou People's Hospital

Haikou, , China

Site Status

The Fourth Affiliated Hospital of Harbin Medical University

Ha’erbin, , China

Site Status

The Second People's Hospital of Hefei

Hefei, , China

Site Status

The First Affiliated Hospital of University of South China

Hengyang, , China

Site Status

Huzhou Central Hospital

Huzhou, , China

Site Status

The First Hospital of Jiaxing

Jiaxing, , China

Site Status

Liuzhou People's Hospital

Liuzhou, , China

Site Status

Liuzhou Workers' Hospital

Liuzhou, , China

Site Status

Luoyang Central Hospital

Luoyang, , China

Site Status

Ma'anshan People's Hospital

Ma’anshan, , China

Site Status

Mianyang Central Hospital

Mianyang, , China

Site Status

JiangXi Provincial People's Hospital

Nanchang, , China

Site Status

The Second Nanning People's Hospital

Nanning, , China

Site Status

The Second People's Hospital of Neijiang

Neijiang, , China

Site Status

Ningbo Medical Center Lihuili Hospital

Ningbo, , China

Site Status

Qingdao Central Hospital of Rehabilitation University

Qingdao, , China

Site Status

Shanghai First Maternity and Infant Hospital

Shanghai, , China

Site Status

Shanghai Fourth People's Hospital

Shanghai, , China

Site Status

Taizhou People's Hospital

Taizhou, , China

Site Status

The Second Hospital of Tianjin Medical University

Tianjin, , China

Site Status

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, , China

Site Status

Wuhan Third Hospital

Wuhan, , China

Site Status

Affiliated Hospital of Jiangnan University

Wuxi, , China

Site Status

The First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, , China

Site Status

Zhongshan Hospital Xiamen University

Xiamen, , China

Site Status

The Second People's Hospital of Yibin

Yibin, , China

Site Status

Zhangzhou Municipal of Fujian Province

Zhangzhou, , China

Site Status

Henan Provincial People's Hospital

Zhengzhou, , China

Site Status

Zhuzhou Central Hospital

Zhuzhou, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Wen Ouyang

Role: CONTACT

0731-88618931

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

YZJ-4729-3-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.